TITLE

Impact of WTO on the Indian pharmaceutical industry

AUTHOR(S)
Tannan, S. K.; Tannan, Prerna
PUB. DATE
April 2004
SOURCE
Chemical Business;Apr/Jun2004, Vol. 18 Issue 2, p56
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Discusses the impact of the amendments in the Indian Patent Act done to meet their obligations to the World Trade Organization on the pharmaceutical industry. Provisions under the Indian Patent Act 1970; Details of the Doha Declaration and its implementation addressing public health problems of developing countries; Benefits of the patent law to consumers and the country's economy.
ACCESSION #
15340316

 

Related Articles

  • Patent policy and public health in developing countries: lessons from Japan. Aoki, Reiko; Kubo, Kensuke; Yamane, Hiroko // Bulletin of the World Health Organization;May2006, Vol. 84 Issue 5, p417 

    The article discusses on the implications of the World Trade Organization's Trade-Related Aspects of Intellectual Property Rights Agreement on the public health sector in developing countries. Under the product patent law, local pharmaceutical companies are restricted to copy manufactured drugs...

  • Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Oliveira, Maria Auxiliadora; Bermudez, Jorge Antonio Zepeda; Chaves, Gabriela Costa; Velásquez, Germán // Bulletin of the World Health Organization;Nov2004, Vol. 82 Issue 11, p815 

    Objective The World Trade Organization's Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement establishes minimum standards for intellectual property rights, including patent protection for pharmaceuticals; therefore, it may make it difficult for developing countries to gain...

  • "No turning back" on cheap AIDS drugs for poor nations, UN vows. Silversides, Ann // CMAJ: Canadian Medical Association Journal;11/11/2003, Vol. 169 Issue 10, p1067 

    Emphasizes the need to modify the Patent Act in Ottawa, Ontario, to allow Canadian manufacturers of generic drugs to make and export drugs to developing countries. Implications of the proposed drug exportation for Canadian pharmaceutical companies; Impact of the decision of the World Trade...

  • Canada to allow production of generic AIDS drugs.  // Nature Reviews Drug Discovery;Nov2003, Vol. 2 Issue 11, p854 

    Reports that Canadian Prime Minister-elect Paul Martin, has endorsed plans for the federal government to excuse poor countries from patent rules. Allowance for Canadian generic-drug makers to supply cheap medicines to developing countries undergoing health crises; Deal of the World Trade...

  • LETTER FROM THE EDITOR. Madrick, Jeff // Challenge (05775132);Nov/Dec2003, Vol. 46 Issue 6, p3 

    The paper introduces a series of articles about economics and international trade. The gap in income and wealth between the rich and the poor countries is ever widening. Ha-Joon Chang is a trade economist and historian who strongly contends that at the heart of trade theory lies a flaw when it...

  • TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana. Cohen, J. C.; Gyansa-Lutterodt, M.; Torpey, K.; Esmail, L. C.; Kurokawa, G. // Globalization & Health;2005, Vol. 1, p17 

    There are acute disparities in pharmaceutical access between developing and industrialized countries. Developing countries make up approximately 80% of the world's population but only represent approximately 20% of global pharmaceutical consumption. Among the many barriers to drug access are the...

  • Global Health Policy And Free Access To Information.  // Health Affairs;May/Jun2004, Vol. 23 Issue 3, p7 

    While many Americans grouse about the high cost of medical care in the United States, their willingness to pay is strong evidence of the value they place on having ready access to these services. But little research has documented why Americans pay so much more than citizens in other...

  • China Joins Global Health Governance: New Player, More Medicines, and New Rules? Lee, Pak K.; Lai-Ha Chan // Global Governance;Apr-Jun2014, Vol. 20 Issue 2, p297 

    In the wake of China's rapid ascendancy, are there any new rules made by the country in global health governance? This article examines China's emerging role in the Agreement on Trade Related Aspects of Intellectual Property Rights and finds that China adopts a pro-status quo stance on patented...

  • WHO criticised for ignoring drug dumping. Wise, Jacqui // BMJ: British Medical Journal (International Edition);09/13/97, Vol. 315 Issue 7109, p626 

    Reports on accusations against the World Health Organization (WHO) for ignoring the problem of standard drugs being dumped in developing countries. WHO's failure to lead the prevention of unacceptable trading practices in supply lines; Consequences of drug dumping; Changes on WHO's work...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics